title: Myriad and its implications for patent protection of isolated natural products in the United States.
abstract: Extracts and compounds of natural products have potential as alternatives to current Western medicines. However, these products may not be patentable under the statutory requirements because of their naturally-occurring nature. This article analyzes the current patenting practices for natural products in the United States, particularly in light of the recent Supreme Court ruling in Myriad, and suggests an advantageous strategy for patenting these products. Briefly, isolated natural products per se are not patentable in the United States. Therefore, patenting focus should be placed on the modification, formulation, manufacture, and application of natural products. A detailed description of each invention is highly recommended for stronger support and broader coverage of the claims.
authors.affiliation: Albert Wai-Kit Chan Intellectual Property Limited, Hong Kong, SAR, China.
authors.forename: Alice Yuen-Ting
authors.initials: AY
authors.lastname: Wong
authors.affiliation: Law Offices of Albert Wai-Kit Chan, PLLC, Whitestone, NY 11357, USA.
authors.forename: Albert Wai-Kit
authors.initials: AW
authors.lastname: Chan